Graham G. Walmsley bought AKRO
October 8, 2025 · Form 4 insider transaction
Graham G. Walmsley bought 26,000 shares of Akero Therapeutics, Inc. at $23.02 per share, a transaction worth $598.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
26,000
Price
$23.02
Total value
$598.5K
InsiderGraham G. Walmsley
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 8, 2025
Filing dateOctober 10, 2025
Shares owned after28,168
OwnershipDirect
10b5-1 planNo
AmendedNo